Nanophase Technologies Corp
OTC:NANX
Balance Sheet
Balance Sheet Decomposition
Nanophase Technologies Corp
Current Assets | 22.1m |
Cash & Short-Term Investments | 2m |
Receivables | 5.2m |
Other Current Assets | 14.8m |
Non-Current Assets | 16.4m |
PP&E | 16.4m |
Other Non-Current Assets | 3k |
Current Liabilities | 12.2m |
Accounts Payable | 6.2m |
Accrued Liabilities | 2.5m |
Short-Term Debt | 850k |
Other Current Liabilities | 2.6m |
Non-Current Liabilities | 15.4m |
Long-Term Debt | 6.2m |
Other Non-Current Liabilities | 9.2m |
Balance Sheet
Nanophase Technologies Corp
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
2
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
2
|
2
|
|
Cash Equivalents |
2
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
2
|
2
|
|
Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Receivables |
0
|
1
|
0
|
1
|
1
|
1
|
3
|
4
|
5
|
3
|
|
Accounts Receivables |
0
|
1
|
0
|
1
|
1
|
1
|
3
|
4
|
5
|
3
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
1
|
1
|
1
|
1
|
2
|
3
|
4
|
6
|
9
|
10
|
|
Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
Total Current Assets |
4
|
3
|
3
|
5
|
5
|
5
|
9
|
12
|
17
|
16
|
|
PP&E Net |
2
|
2
|
1
|
2
|
2
|
4
|
5
|
17
|
17
|
17
|
|
PP&E Gross |
0
|
0
|
0
|
0
|
0
|
4
|
5
|
17
|
17
|
17
|
|
Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
20
|
20
|
21
|
21
|
22
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Assets |
6
N/A
|
5
-20%
|
5
+6%
|
6
+30%
|
7
+5%
|
9
+43%
|
14
+45%
|
28
+110%
|
34
+18%
|
33
-2%
|
|
Liabilities | |||||||||||
Accounts Payable |
0
|
1
|
1
|
1
|
2
|
2
|
2
|
4
|
6
|
6
|
|
Accrued Liabilities |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
2
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
1
|
1
|
3
|
1
|
7
|
3
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
2
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
|
Total Current Liabilities |
1
|
1
|
1
|
2
|
4
|
4
|
7
|
7
|
17
|
16
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
6
|
|
Other Liabilities |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
13
|
10
|
9
|
|
Total Liabilities |
2
N/A
|
2
-9%
|
2
+20%
|
3
+48%
|
5
+71%
|
8
+51%
|
11
+38%
|
21
+94%
|
28
+33%
|
31
+11%
|
|
Equity | |||||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
92
|
94
|
95
|
96
|
98
|
101
|
100
|
97
|
100
|
105
|
|
Additional Paid In Capital |
96
|
96
|
97
|
99
|
99
|
102
|
102
|
104
|
105
|
106
|
|
Total Equity |
4
N/A
|
3
-26%
|
3
-2%
|
3
+16%
|
1
-57%
|
2
+9%
|
3
+81%
|
7
+174%
|
6
-24%
|
2
-66%
|
|
Total Liabilities & Equity |
6
N/A
|
5
-20%
|
5
+6%
|
6
+30%
|
7
+5%
|
9
+43%
|
14
+45%
|
28
+110%
|
34
+18%
|
33
-2%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
29
|
29
|
31
|
34
|
34
|
38
|
38
|
49
|
49
|
50
|